[1]
2022. ASSESSMENT OF INJECTION SITE REACTION IN PATIENTS TREATED WITH BIOLOGIC DRUGS FOR SUBCUTANEOUS ADMINISTRATION. Journal of Pharmaceutical Negative Results. 13, 3 (Sep. 2022), 523–528. DOI:https://doi.org/10.47750/pnr.2022.13.03.080.